Skip to main content
. 2018 Apr 5;10(4):e2431. doi: 10.7759/cureus.2431

Table 1. Clinically used dose criteria for MR-linac treatment of lumbar spine bone metastases for planning and plan evaluation.

Structure Constraint
Planning Target Volume (PTV) V7.2Gy > 90%,
  D98% > 6.4Gy
  D0.1cc < 8.8Gy
Spinal Cord D0.1cc < 8.6Gy
Body D0.1cc < 8.8Gy